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. Structural studies comparing binding modes of methylidene indolinone-based kinase inhibitors 11 and 15 (A) with active and inactive kinase domains. Compound 15 (A) was cocrystallised with RET kinase domain (B, PDB: 2X2K) forcing a "DFG-in" kinase conformation. This 15-bound RET conformation was aligned with the PDGFRA crystal structure (B, PDB: 5K5X) revealing gross conformational shifts around the ATP-binding pocket, particularly between the RET and PDGFRA b-hairpin and Ca-helix (B), and compared to RET, the PDGFRA DFG catalytic-motif aspartic acid is pointing outside of the ATP-binding pocket; evidence for an inactive kinase conformation. Compound 11 displayed the greatest potency in the series against PDGFRA, a receptor tyrosine kinase containing a threonine gatekeeper. RET has a valine gatekeeper, and thus PTK6 (C, PDB: 5DA3), a non-receptor tyrosine kinase containing a threonine gatekeeper, was selected for docking studies with compound 10 -11 (Fig. 5, main article) to ascertain the molecular determinants for the superior potency of 11 vs 10. The alignment between 15-bound RET and 11-docked PTK6 (C) reveals very similar binding modes between compounds 11 and 15 and an agreement in PTK6 and RET kinase conformation, both in the active state. -10  0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 ( 
